Prognosis Of Mesothelioma

Prognosis Of Mesothelioma

In general the prognosis of mesothelioma is poor and most studies report median survival of less than a year. However, there are long term mesothelioma survivors (these include both pleural and peritoneal survivors) who have survived more than 10 years.

One mesothelioma study said that long-term mesothelioma survivors do exist and their prognosis may be independent of the treatment or therapies pursued. If true, this would suggest that mesothelioma prognosis and survival may be more dependent on the individual differences between patients (and maybe even the non-conventional therapies that they use) and less dependent upon conventional mesothelioma treatments.

Since conventional therapies are not helping the overwhelming majority of mesothelioma patients, researchers are investigating new types of mesothelioma treatments and therapies. One approach that may yield promising results is anti-angiogenesis. Anti-angiogenesis is a form of therapy that uses drugs or other substances to stop tumors from making new blood vessels. Without a blood supply, the cancers cannot grow effectively. Today, there are several hundred clinical trials of anti-angiogenesis drugs under way.

Surviving Mesothelioma and Other Cancers: A Patient's Guide - This book is written by ten-year mesothelioma survivor, Paul Kraus. He also speaks directly to newly diagnosed mesothelioma patients during frequent teleconferences. You can get a copy of his book HERE.

The prognosis of mesothelioma is improving as new drugs and new techniques are employed to combat this illness. Listed below are some important links for staying up-to-date with the latest strategies for fighting Mesothelioma.

National Cancer Institute, Mesothelioma Q&A Link

For more help, contact:

NCI's Cancer Information Service
Telephone (toll-free): 1–800–4–CANCER (1–800–422–6237)